Marina Vaysburd, M.D.
Medical Oncology Physician · Beverly Hills, CA
Marina Vaysburd, M.D. is a medical oncology physician with a practice address in Beverly Hills, California, and NPI 1689784712, issued on Aug 30, 2006. Check the license (California A64864, as entered in NPPES) on the Medical Board of California; the Medicare figures below come from public CMS files.
- Name
- Marina Vaysburd
- Credential
- M.D.
- Primary taxonomy
- Medical Oncology Physician 207RX0202X
- License number
- A64864 CA
Self-reported in NPPES; status is on the state search - Practice location
- 200 N Robertson Blvd, Beverly Hills, CA 90211
- Phone
- (310) 967-1884
- Enumerated
- Aug 30, 2006
- Record last updated
- Mar 17, 2016 (not updated in 10 years: call before relying on the address or phone)
- Fax
- (310) 967-1744
- Medicare enrollment
- Enrolled (PECOS I20041102001205); accepts Medicare assignment
- Medical or professional school
- Stanford University School Of Medicine, 1996
- Telehealth
- Offers telehealth (CMS)
- Entity
- Type 1 · individual
Also registered at 200 N Robertson Blvd
A shared address usually means a shared clinic or building; it does not show who employs whom.
- Raul Banuelos, DPTPhysical Therapist1497864219
- Josephine Bicknell, FNPFamily Nurse Practitioner1811328792
- Stephanie Bolling, MS, PT, OCSPhysical Therapist1538194568
- Jeffrey Brown, M.D.Pediatrics Physician1013929611
- Noam Drazin, M.D.Medical Oncology Physician1952313520
- Kate Fan, ODOptometrist1316618481
Verify Marina Vaysburd in five checks
- 1IdentityNPI record in CMS NPPESNPI lookupConfirmed in NPPES
- 2LicenseActive license and public ordersMedical Board of California
Search for license A64864Check the board - 3Other statesLicenses and actions elsewhereDocInfo (FSMB)Not checked
- 4ExclusionsMedicare and Medicaid bansHHS-OIG exclusion listNot checked
- 5CertificationBoard certificationABMS AOA NCCPA AANPNot checked
27% more Medicare Part D claims than the average medical oncology physician in 2024
892 Medicare Part D claims for 177 beneficiaries, against an average of 703 among the 4,230 providers of this specialty who prescribed in Part D. Brand-name drugs were 8% of claims.
Most prescribed
- Letrozole485 claims
- Tamoxifen Citrate98 claims
- Hydroxyurea84 claims
- Anastrozole33 claims
- Raloxifene Hcl32 claims
- Exemestane28 claims
Source: CMS Medicare Part D Prescribers by Provider and Drug, 2024 (data.cms.gov). Part D covers prescriptions for Medicare patients only; drugs with fewer than 11 claims are not published.
The practice group's MIPS final score for 2023 (Medicare payment program): 85.7 of 100
The Merit-based Incentive Payment System score is reported for the practice group, not for one clinician alone. Four categories are weighted into the final score; the average among 454,083 clinicians with a measured score was 83.5.
Source: CMS Quality Payment Program, MIPS performance year 2023, group reporting; category weights for 2023 (qpp.cms.gov).
Industry payments in 2024: $2,061.72
8 payments; by number, the most common kind was food and beverage; the largest payer was AstraZeneca Pharmaceuticals LP. The 3,343 providers of this specialty with any payment received $11,773.47 on average. Payments are reported by manufacturers, not by the provider, and are not a sign of wrongdoing.
Source: CMS Open Payments, program year 2024 (openpaymentsdata.cms.gov); average among providers of this specialty with at least one payment.
Bills Medicare through one group practice
- Cedars-Sinai Medical Care FoundationLos Angeles, CA
Source: CMS Doctors and Clinicians National Downloadable File (the group practices a clinician bills Medicare through) (data.cms.gov).
Medical Oncology Physician providers in California
There are 447 medical oncology physician records in California.
Other medical oncology physician records in California
- Donald Abrams, MDSan Francisco, CA1679530018
- Ranjana Advani, MDStanford, CA1639225121
- Kambiz Afrasiabi, M.D.Anaheim, CA1578572368
- Mark Agulnik, MDLos Angeles, CA1164448734
- David Agus, M.D.Los Angeles, CA1356328249
- Weiyun Ai, MDSan Francisco, CA1649346842
- Shafqat Akhtar, MDRed Bluff, CA1700960788
- Luai Al Rabadi, M.D.San Francisco, CA1659637452
- Michael Alexander, MDSanta Cruz, CA1053321760
- Sandra AlgazeLos Angeles, CA1861886707
Common questions
What is Marina Vaysburd, M.D.'s NPI number?
Marina Vaysburd, M.D.'s National Provider Identifier (NPI) is 1689784712, issued on Aug 30, 2006. An NPI identifies a provider in billing; it is not a license.
Where is Marina Vaysburd, M.D. located?
The NPPES record lists a practice address at 200 N Robertson Blvd, Beverly Hills, CA, 90211. Phone: (310) 967-1884. Providers update this record themselves, so call before visiting.
How can I verify Marina Vaysburd, M.D.'s license?
NPPES lists California license number A64864, as entered by the provider. Search the Medical Board of California at https://www.mbc.ca.gov/License-Verification/default.aspx. The NPPES record confirms identity only; the state search shows license status, expiration and public orders.
How much does Marina Vaysburd, M.D. prescribe under Medicare Part D?
In 2024, Marina Vaysburd, M.D. had 892 Medicare Part D claims for 177 beneficiaries; the average among medical oncology physician prescribers was 703. Part D covers Medicare prescriptions only.
What is Marina Vaysburd, M.D.'s MIPS final score?
The 2023 MIPS final score is 85.7 of 100, reported for the practice group. The average among 454,083 clinicians with a measured score was 83.5.
Source: CMS National Plan and Provider Enumeration System (NPPES), file of Aug 9, 2026 (NPPES files on CMS.gov); NUCC Health Care Provider Taxonomy. Medicare files from data.cms.gov. An NPI identifies who bills; it is not a license.
Figures on PlainDoctor are read from the federal files each page names (CMS NPPES, Medicare Part D, MIPS, Open Payments; the HHS-OIG exclusion list only as counts) and from Census population estimates, with the file date shown beside them. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of Aug 9, 2026.